Amneal launches PEMRYDI RTU, ready-to-use version of pemetrexed, oncology injectable medicine
PEMRYDI RTU injectable is available in two vial sizes: 100mg/10mL and 500 mg/50mL
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Amneal Pharmaceuticals
Charting India Pharma Inc’s growth path
Pharma leaders and experts highlight opportunities in the life sciences industry, address critical issues and explore development…
Delegation from US HHS, US FDA, and local govt officials visit Amneal’s Matoda facility
The delegation included Loyce Pace, the Assistant Secretary for Global Affairs, Genessa Giorgi, US HHS Health Attaché to India, Dr…
Amneal Pharma acquires injectable firm Punishka Healthcare for Rs 700 crores
The acquisition significantly enhances Amneal’s injectables manufacturing infrastructure, capabilities, and capacity to support…
US FDA accepts Amneal’s Biologics License Application for Bevacizumab
Bevacizumab represents the third biosimilar BLA currently filed by Amneal with the FDA
Amneal completes acquisition of Kashiv Specialty Pharmaceuticals
Kashiv Specialty Pharmaceuticals is focused on the development of complex generics, innovative drug delivery platforms and novel…
Amneal gets USFDA approval for Norelgestromin and Ethinyl Estradiol Transdermal System
The company granted 180 days of exclusivity under FDA Competitive Generic Therapy (CGT) approval pathway
Amneal launches Generic Abiraterone Acetate Tablets, following US FDA approval
They are indicated for treatment of metastatic prostate cancer
Amneal gets US FDA approval for Acyclovir Cream
It is indicated for the treatment of recurrent herpes labialis (cold sores) in immunocompetent adults and adolescents 12 years of…
Amneal gets US FDA approval for Lidocaine Patch
It is indicated for the treatment of post-herpetic neuralgia